# GLP-1s and Lower Risk of Cirrhosis – A new study reveals that GLP-1s could reduce the risk of liver cirrhosis in individuals with diabetes and metabolic-associated fatty liver disease (MAFLD). – GLP-1s, commonly used to treat type 2 diabetes, were found to have a protective effect on the liver. – The study suggests that GLP-1s may offer benefits beyond glycemic control and weight loss for individuals with certain metabolic conditions. – These findings open up new possibilities for the use of GLP-1s in managing liver health in diabetic patients. ### GLP-1s as a Protective Measure GLP-1s have shown promise in not only managing diabetes but also in potentially lowering the risk of liver cirrhosis, especially in individuals with underlying metabolic issues. This study sheds light on the additional benefits that GLP-1s can offer beyond their primary indications. As healthcare providers continue to explore novel treatment options, utilizing GLP-1s for their liver-protective properties could be a game-changer for individuals with diabetes and metabolic-associated fatty liver disease. **Contact Mindful Evolution today to learn more about how telehealth services can support your weight loss journey in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Call or text us at 954-639-9960 or visit our website https://yourmindfulevolution.com.** *Weight Loss Disclaimer: Individual results may vary. Always consult with a healthcare provider before starting any weight loss program.*